Search

everythinglearnresearchcommunity

for

Search:↓

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Tadalafil and Finasteride may help treat aggressive melanoma.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

The model and estimator can predict drug exposure in kidney transplant patients well.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Some medications can cause acne, and stopping these drugs is the main treatment.

Type I interferons play a key role in the development of various skin diseases.

Annurca apple supplement safely increases hair growth and keratin in humans.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Hair graying is influenced by factors like nerves, fat cells, and immune cells, not just hair follicles.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Dutasteride and minoxidil mesotherapy effectively treats hair loss with minimal side effects.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Chemotherapy often causes hair loss in cancer patients, affecting their mental health, but scalp cooling can help prevent it.

Activating β-catenin increases melanocytes and decreases Schwann cells.

A new cosmetic cream reduced facial redness and skin temperature after 4 weeks of use.

Regular follow-up visits, especially with dermatologists, can lower death rates for melanoma patients, with socioeconomic factors also affecting outcomes.

Melanoma survival rates vary by state and are better where incomes are higher, more people have health insurance and education, and there are more dermatologists.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.

The conclusion is that grasping how cells determine their roles through evolution is key, with expected progress from new research models and genome editing.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.